IBRD only vs Naoero: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- IBRD only
- Naoero
How they compare
Naoero currently reports 34.8% against 22.1% in IBRD only, a difference of 12.7%.
That makes Naoero's figure about 1.6 times IBRD only's.
Across all 9 years both countries report, Naoero has been ahead every year.
IBRD only ranks 16th and Naoero ranks 14th of 46 groups.
Naoero has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IBRD only | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.6% | 59.3% | 26.7% | Naoero |
| 2010s | 27.4% | 47.1% | 19.7% | Naoero |
| 2020s | 22.8% | 36.4% | 13.6% | Naoero |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, IBRD only or Naoero?
- Naoero, at 34.8% against 22.1% in IBRD only as of 2024.
- What is the difference in prevalence of current tobacco use between IBRD only and Naoero?
- 12.7%, with Naoero ahead.
- How many years of comparable data are there for IBRD only and Naoero?
- 9 years are reported by both, from 2000 to 2024.
- How do IBRD only and Naoero rank globally for prevalence of current tobacco use?
- IBRD only ranks 16th and Naoero ranks 14th of 46 groups.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.